Vitamin C has been identified as a potent inhibitor of the lipid metabolism enzyme **ACSL4, which plays a crucial role in the process termed ferro-aging—a mechanism where age-related iron accumulation leads to oxidative stress and cellular senescence. In a recent study involving cynomolgus monkeys, researchers demonstrated that vitamin C supplementation significantly suppressed ACSL4 activity and ferro-aging biomarkers, suggesting a direct link between vitamin C and improved aging outcomes.**

The study’s findings are significant as they establish a clear mechanistic connection between iron metabolism, oxidative stress, and aging. The researchers observed that in aged human and monkey tissues, there was a marked increase in iron levels and ACSL4 expression, correlating with heightened lipid peroxidation and senescence markers. Notably, vitamin C treatment in monkeys resulted in reduced expression of ferro-aging-related genes, lower plasma iron levels, and improved metabolic parameters across multiple organs, including the brain and cardiovascular system. These results indicate that vitamin C not only mitigates oxidative damage but also enhances the antioxidant response, effectively countering the detrimental effects of ferro-aging.

The implications of this research are profound for the field of aging biology and therapeutic development. By identifying ACSL4 as a druggable target in the context of ferro-aging, the study opens avenues for potential interventions aimed at delaying age-related decline. The positive outcomes observed in cynomolgus monkeys, which closely resemble human aging, underscore the necessity for further exploration of vitamin C’s therapeutic potential in human clinical trials. This research could shift current paradigms in aging interventions, emphasizing the role of micronutrients in modulating age-related pathways and potentially leading to novel strategies for enhancing healthspan.

Source: lifespan.io